Related Experiment Video
Updated: May 29, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
Tigecycline attenuates polymorphonuclear leukocyte (PMN) receptors but not functions
Are Naess1, Hristina Andreeva, Steinar Sørnes
1Institute of Medicine, University of Bergen, Haukeland University Hospital, N-5021Bergen, Norway.
Abstract:
Tigecycline achieves high intracellular concentrations in polymorphonuclear leukocytes (PMNs). To evaluate the effects of tigecycline on human PMNs, PMNs were incubated with tigecycline dilutions (0.1 to 100 mg L-1). Phagocytosis-associated PMN Fcγ- and complement receptors as well as phagocytosis and oxidative burst induced by Staphylococcus aureus were measured by flow cytometry. Incubation with tigecycline caused small but significant decreases in the density of complement receptors CD11b and CD35 (all concentrations) and Fcγ receptors CD16 and CD32 (high concentrations), but not in the percentages of receptor-bearing cells, except for small reductions in the proportions of CD16 positive cells at high concentrations. Tigecycline had no effect on phagocytosis or oxidative burst induced by S. aureus. Tigecycline was thus associated with decreased density of PMN complement and (at high concentrations) Fcγ receptors. Although statistically significant, the differences were small and did not influence the PMN function as measured by phagocytosis and oxidative burst.
Insights
Tigecycline slightly reduced immune cell receptors at high doses but did not impact Staphylococcus aureus phagocytosis or oxidative burst in polymorphonuclear leukocytes (PMNs). This antibiotic maintains crucial immune cell functions.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Tigecycline achieves high intracellular concentrations within polymorphonuclear leukocytes (PMNs).
- Understanding tigecycline's impact on PMN function is crucial for its clinical application.
- PMNs play a vital role in the innate immune response against bacterial infections.
Purpose of the Study:
- To evaluate the effects of tigecycline on human PMN receptors and functions.
- To assess if tigecycline influences phagocytosis and oxidative burst induced by Staphylococcus aureus.
Main Methods:
- Human PMNs were incubated with varying concentrations of tigecycline (0.1 to 100 mg L-1).
- Flow cytometry was used to measure PMN Fcγ receptors (CD16, CD32) and complement receptors (CD11b, CD35).
- Phagocytosis and oxidative burst assays using Staphylococcus aureus were performed.
Main Results:
- Tigecycline caused minor, concentration-dependent decreases in the density of complement receptors CD11b and CD35, and Fcγ receptors CD16 and CD32.
- The percentage of receptor-bearing cells remained largely unaffected, except for a slight reduction in CD16 positive cells at high concentrations.
- Tigecycline did not alter phagocytosis or oxidative burst activity of PMNs against Staphylococcus aureus.
Conclusions:
- Tigecycline is associated with reduced PMN complement and Fcγ receptor density, particularly at high concentrations.
- These minor changes in receptor density did not significantly impair PMN phagocytosis or oxidative burst functions.
- Tigecycline appears to preserve key PMN functions essential for combating bacterial infections like those caused by Staphylococcus aureus.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
GPCRs Regulate Adenylyl Cylase Activity
Two...
Desensitization and Tachyphylaxis
Several...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
